Theratechnologies Inc. (TH.TO)
CAD 3.69
(3.94%)
CAD 3.69
(3.94%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 81.76 Million USD | 2.13% |
| 2022 | 80.05 Million USD | 14.66% |
| 2021 | 69.82 Million USD | 5.71% |
| 2020 | 66.05 Million USD | 4.49% |
| 2019 | 63.21 Million USD | 43.35% |
| 2018 | 44.09 Million USD | 32.4% |
| 2017 | 33.3 Million USD | 20.71% |
| 2016 | 27.59 Million USD | 22.76% |
| 2015 | 22.47 Million USD | 282.45% |
| 2014 | 5.87 Million USD | -17.39% |
| 2013 | 7.11 Million USD | -47.91% |
| 2012 | 13.65 Million USD | -5.53% |
| 2011 | 14.45 Million USD | -53.75% |
| 2010 | 31.25 Million USD | 89.27% |
| 2009 | 16.51 Million USD | 676.6% |
| 2008 | 2.12 Million USD | -32.11% |
| 2007 | 3.13 Million USD | 116.84% |
| 2006 | 1.44 Million USD | -89.75% |
| 2005 | 14.09 Million USD | 531.74% |
| 2004 | 2.23 Million USD | -27.71% |
| 2003 | 3.08 Million USD | -43.65% |
| 2002 | 5.47 Million USD | 91.53% |
| 2001 | 2.85 Million USD | 256.35% |
| 2000 | 802.46 Thousand USD | -21.22% |
| 1999 | 1.01 Million USD | 42.24% |
| 1998 | 716.14 Thousand USD | 154.77% |
| 1997 | 281.09 Thousand USD | -24.24% |
| 1996 | 371.05 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 22.01 Million USD | 35.51% |
| 2024 Q1 | 16.24 Million USD | -30.72% |
| 2024 Q3 | 22.6 Million USD | 2.65% |
| 2023 FY | 81.76 Million USD | 2.13% |
| 2023 Q4 | 23.45 Million USD | 12.45% |
| 2023 Q2 | 17.54 Million USD | -11.85% |
| 2023 Q1 | 19.9 Million USD | -7.06% |
| 2023 Q3 | 20.85 Million USD | 18.84% |
| 2022 Q4 | 21.42 Million USD | 2.93% |
| 2022 Q3 | 20.81 Million USD | 8.01% |
| 2022 Q2 | 19.26 Million USD | 3.83% |
| 2022 FY | 80.05 Million USD | 14.66% |
| 2022 Q1 | 18.55 Million USD | -1.05% |
| 2021 Q3 | 17.85 Million USD | 0.37% |
| 2021 FY | 69.82 Million USD | 5.71% |
| 2021 Q4 | 18.75 Million USD | 5.05% |
| 2021 Q1 | 15.43 Million USD | -19.31% |
| 2021 Q2 | 17.78 Million USD | 15.28% |
| 2020 Q2 | 17.16 Million USD | 9.18% |
| 2020 Q1 | 15.71 Million USD | -4.15% |
| 2020 FY | 66.05 Million USD | 4.49% |
| 2020 Q4 | 19.12 Million USD | 36.12% |
| 2020 Q3 | 14.04 Million USD | -18.14% |
| 2019 Q4 | 16.4 Million USD | 1.79% |
| 2019 Q2 | 15.6 Million USD | 3.4% |
| 2019 Q1 | 15.09 Million USD | 15.22% |
| 2019 FY | 63.21 Million USD | 43.35% |
| 2019 Q3 | 16.11 Million USD | 3.22% |
| 2018 Q4 | 13.1 Million USD | -3.94% |
| 2018 FY | 44.09 Million USD | 32.4% |
| 2018 Q1 | 7.99 Million USD | -14.27% |
| 2018 Q2 | 9.55 Million USD | 19.51% |
| 2018 Q3 | 13.63 Million USD | 42.69% |
| 2017 Q1 | 6.84 Million USD | -4.87% |
| 2017 FY | 33.3 Million USD | 20.71% |
| 2017 Q4 | 9.32 Million USD | 4.99% |
| 2017 Q3 | 8.88 Million USD | 19.52% |
| 2017 Q2 | 7.43 Million USD | 8.55% |
| 2016 FY | 27.59 Million USD | 22.76% |
| 2016 Q1 | 6.45 Million USD | -2.03% |
| 2016 Q2 | 6.92 Million USD | 7.27% |
| 2016 Q3 | 6.81 Million USD | -1.49% |
| 2016 Q4 | 7.2 Million USD | 5.61% |
| 2015 Q2 | 5.85 Million CAD | 60.34% |
| 2015 Q1 | 3.65 Million USD | 71.11% |
| 2015 Q4 | 6.58 Million USD | -5.14% |
| 2015 FY | 22.47 Million USD | 282.45% |
| 2015 Q3 | 6.94 Million USD | 18.52% |
| 2014 FY | 5.87 Million USD | -17.39% |
| 2014 Q4 | 2.13 Million USD | 57938.32% |
| 2014 Q3 | 3678.70 USD | -99.83% |
| 2014 Q2 | 2.2 Million USD | 46.76% |
| 2014 Q1 | 1.5 Million USD | 32.81% |
| 2013 FY | 7.11 Million USD | -47.91% |
| 2013 Q2 | 2.26 Million USD | 28.7% |
| 2013 Q4 | 1.13 Million USD | -45.21% |
| 2013 Q1 | 1.75 Million USD | -55.2% |
| 2013 Q3 | 2.06 Million USD | -8.69% |
| 2012 Q4 | 3.92 Million USD | 1.91% |
| 2012 FY | 13.65 Million USD | -5.53% |
| 2012 Q3 | 3.84 Million USD | 49.32% |
| 2012 Q2 | 2.57 Million USD | -19.67% |
| 2012 Q1 | 3.2 Million USD | -13.58% |
| 2011 Q3 | 3.59 Million USD | 0.76% |
| 2011 Q2 | 3.56 Million USD | -0.88% |
| 2011 Q1 | 3.59 Million USD | -86.37% |
| 2011 FY | 14.45 Million USD | -53.75% |
| 2011 Q4 | 3.71 Million USD | 3.34% |
| 2010 Q4 | 26.4 Million USD | 1530.45% |
| 2010 Q3 | 1.61 Million USD | -0.5% |
| 2010 Q2 | 1.62 Million USD | -0.38% |
| 2010 Q1 | 1.63 Million USD | -23.48% |
| 2010 FY | 31.25 Million USD | 89.27% |
| 2009 Q3 | 11.5 Million USD | 630.38% |
| 2009 Q2 | 1.57 Million USD | 39.65% |
| 2009 FY | 16.51 Million USD | 676.6% |
| 2009 Q4 | 2.13 Million USD | -81.44% |
| 2009 Q1 | 1.12 Million USD | 411.92% |
| 2008 Q4 | 220.33 Thousand CAD | -67.03% |
| 2008 Q2 | 715.07 Thousand CAD | 17.0% |
| 2008 Q1 | 611.16 Thousand CAD | -56.05% |
| 2008 FY | 2.12 Million USD | -32.11% |
| 2008 Q3 | 668.36 Thousand CAD | -6.53% |
| 2007 Q4 | 1.39 Million CAD | 96.36% |
| 2007 Q2 | 748.01 Thousand CAD | 205.06% |
| 2007 FY | 3.13 Million USD | 116.84% |
| 2007 Q1 | 245.2 Thousand CAD | -13.91% |
| 2007 Q3 | 708.13 Thousand CAD | -5.33% |
| 2006 Q3 | 372.71 Thousand CAD | 10159.45% |
| 2006 FY | 1.44 Million USD | -89.75% |
| 2006 Q1 | 417.45 Thousand CAD | -17.09% |
| 2006 Q2 | 3632.90 CAD | -99.13% |
| 2006 Q4 | 284.82 Thousand CAD | -23.58% |
| 2005 FY | 14.09 Million USD | 531.74% |
| 2005 Q4 | 503.52 Thousand CAD | 46.23% |
| 2005 Q3 | 344.34 Thousand USD | -31.52% |
| 2005 Q2 | 502.84 Thousand CAD | -95.89% |
| 2005 Q1 | 12.23 Million CAD | 1953.06% |
| 2004 FY | 2.23 Million USD | -27.71% |
| 2004 Q4 | 596.15 Thousand CAD | 33.77% |
| 2004 Q3 | 445.65 Thousand USD | -22.36% |
| 2004 Q1 | 583.82 Thousand CAD | -30.53% |
| 2004 Q2 | 573.98 Thousand CAD | -1.69% |
| 2003 FY | 3.08 Million USD | -43.65% |
| 2003 Q4 | 840.38 Thousand CAD | 23.63% |
| 2003 Q3 | 679.76 Thousand CAD | -9.24% |
| 2003 Q2 | 748.99 Thousand CAD | -2.51% |
| 2003 Q1 | 768.24 Thousand CAD | 2.29% |
| 2002 Q1 | - CAD | -100.0% |
| 2002 Q3 | 886.16 Thousand CAD | -5.7% |
| 2002 Q4 | 751.02 Thousand CAD | -15.25% |
| 2002 FY | 5.47 Million USD | 91.53% |
| 2002 Q2 | 939.71 Thousand CAD | 0.0% |
| 2001 FY | 2.85 Million USD | 256.35% |
| 2001 Q4 | 2.6 Million CAD | 404242.84% |
| 2001 Q3 | 645.30 CAD | -98.16% |
| 2001 Q2 | 35.12 Thousand CAD | -83.84% |
| 2001 Q1 | 217.36 Thousand CAD | 244.56% |
| 2000 FY | 802.46 Thousand USD | -21.22% |
| 2000 Q1 | 344.57 Thousand CAD | 59.73% |
| 2000 Q2 | 200.22 Thousand USD | -41.89% |
| 2000 Q3 | 148.69 Thousand USD | -25.74% |
| 2000 Q4 | 63.08 Thousand CAD | -57.57% |
| 1999 Q4 | 215.73 Thousand USD | -35.52% |
| 1999 Q2 | 203.46 Thousand USD | 53.46% |
| 1999 Q1 | 132.58 Thousand USD | -60.6% |
| 1999 FY | 1.01 Million USD | 42.24% |
| 1999 Q3 | 334.54 Thousand USD | 64.43% |
| 1998 FY | 716.14 Thousand USD | 154.77% |
| 1998 Q4 | 336.49 Thousand USD | 165.9% |
| 1998 Q1 | 70.26 Thousand USD | -48.75% |
| 1998 Q3 | 126.55 Thousand USD | -38.56% |
| 1998 Q2 | 205.95 Thousand USD | 193.12% |
| 1997 Q1 | 73.06 Thousand USD | 0.0% |
| 1997 FY | 281.09 Thousand USD | -24.24% |
| 1997 Q2 | 145.11 Thousand USD | 98.61% |
| 1997 Q3 | 71.99 Thousand USD | -50.39% |
| 1997 Q4 | 137.1 Thousand USD | 90.44% |
| 1996 FY | 371.05 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aurora Cannabis Inc. | 270.28 Million CAD | 69.749% |
| Avicanna Inc. | 16.79 Million CAD | -386.937% |
| Avant Brands Inc. | 26.34 Million CAD | -210.37% |
| Cardiol Therapeutics Inc. | - CAD | -Infinity% |
| Crescita Therapeutics Inc. | 17.52 Million CAD | -366.636% |
| Knight Therapeutics Inc. | 328.19 Million CAD | 75.087% |
| MediPharm Labs Corp. | 33.06 Million CAD | -147.305% |
| OrganiGram Holdings Inc. | 149.2 Million CAD | 45.2% |
| Canopy Growth Corporation | 297.14 Million CAD | 72.484% |
| Willow Biosciences Inc. | 1.17 Million CAD | -6876.451% |
| Auxly Cannabis Group Inc. | 101.07 Million CAD | 19.108% |